Snir Afik D, Raju Hariharan
Royal Prince Alfred Hospital Sydney, Australia.
Faculty of Medicine and Health Sciences, Macquarie University Sydney, Australia.
Eur Cardiol. 2019 Dec 18;14(3):169-174. doi: 10.15420/ecr.2019.12.2. eCollection 2019 Dec.
More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional risk modification strategies as well as our current pathophysiological understanding of the disease.
自1993年首次被描述以来的三十多年里, Brugada综合征仍深陷争议之中。本综述旨在阐明围绕诊断途径和标准、无症状患者的风险分层、药物和介入性风险修正策略以及我们目前对该疾病病理生理学理解的主要挑战。